1. INTRODUCTION
1.1.Market Overview
1.2.Market Definition
1.3.Scope of the Study
1.4.Market Segmentation
1.5.Currency
1.6.Assumptions
1.7.Base, and Forecast Years Timeline
1.8.Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1.Research Design
2.2.Research Processes
3. EXECUTIVE SUMMARY
3.1.Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1.Market Drivers
4.2.Market Restraints
4.3.Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4.Industry Value Chain Analysis
4.5. Analyst View
5. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SOURCE
5.1.Introduction
5.2.Mammalian
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.3.Non-mammalian
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
6. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY PRODUCT TYPE
6.1.Introduction
6.2.Biologics
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Monoclonal antibodies (MABs)
6.2.4. Recombinant Proteins
6.2.5. Vaccines
6.2.6. Antisense, RNAi, & Molecular Therapy
6.2.7. Others
6.3.Biosimilars
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
7. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SERVICE
7.1.Introduction
7.2.Process Development
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Downstream
7.2.4. Upstream
7.3.Fill & Finish Operations
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.4.Analytical and QC studies
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.5.Packaging and Labeling
7.5.1. Market Opportunities and Trends
7.5.2. Growth Prospects
8. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY SCALE OF OPERATION
8.1.Introduction
8.2.Commercial Operations
8.2.1. Market Opportunities and Trends
8.2.2. Growth Prospects
8.3.Clinical Operations
8.3.1. Market Opportunities and Trends
8.3.2. Growth Prospects
9. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY THERAPEUTIC AREA
9.1.Introduction
9.2.Oncology
9.2.1. Market Opportunities and Trends
9.2.2. Growth Prospects
9.3.Autoimmune Diseases
9.3.1. Market Opportunities and Trends
9.3.2. Growth Prospects
9.4.Metabolic Diseases
9.4.1. Market Opportunities and Trends
9.4.2. Growth Prospects
9.5.Cardiovascular Diseases
9.5.1. Market Opportunities and Trends
9.5.2. Growth Prospects
9.6.Neurology
9.6.1. Market Opportunities and Trends
9.6.2. Growth Prospects
9.7.Infectious Diseases
9.8.Others
9.8.1. Market Opportunities and Trends
9.8.2. Growth Prospects
10. BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET BY GEOGRAPHY
10.1.Introduction
10.2.North America
10.2.1. By Source
10.2.2. By Product Type
10.2.3. By Service
10.2.4. By Scale of Operation
10.2.5. By Therapeutic Area
10.2.6. By Country
10.2.6.1. United States
10.2.6.1.1. Market Opportunities and Trends
10.2.6.1.2. Growth Prospects
10.2.6.2. Canada
10.2.6.2.1. Market Opportunities and Trends
10.2.6.2.2. Growth Prospects
10.2.6.3. Mexico
10.2.6.3.1. Market Opportunities and Trends
10.2.6.3.2. Growth Prospects
10.3.South America
10.3.1. By Source
10.3.2. By Product Type
10.3.3. By Service
10.3.4. By Scale of Operation
10.3.5. By Therapeutic Area
10.3.6. By Country
10.3.6.1. Brazil
10.3.6.1.1. Market Opportunities and Trends
10.3.6.1.2. Growth Prospects
10.3.6.2. Argentina
10.3.6.2.1. Market Opportunities and Trends
10.3.6.2.2. Growth Prospects
10.3.6.3. Others
10.3.6.3.1. Market Opportunities and Trends
10.3.6.3.2. Growth Prospects
10.4.Europe
10.4.1. By Source
10.4.2. By Product Type
10.4.3. By Service
10.4.4. By Scale of Operation
10.4.5. By Therapeutic Area
10.4.6. By Country
10.4.6.1. United Kingdom
10.4.6.1.1. Market Opportunities and Trends
10.4.6.1.2. Growth Prospects
10.4.6.2. Germany
10.4.6.2.1. Market Opportunities and Trends
10.4.6.2.2. Growth Prospects
10.4.6.3. France
10.4.6.3.1. Market Opportunities and Trends
10.4.6.3.2. Growth Prospects
10.4.6.4. Italy
10.4.6.4.1. Market Opportunities and Trends
10.4.6.4.2. Growth Prospects
10.4.6.5. Spain
10.4.6.5.1. Market Opportunities and Trends
10.4.6.5.2. Growth Prospects
10.4.6.6. Others
10.4.6.6.1. Market Opportunities and Trends
10.4.6.6.2. Growth Prospects
10.5.Middle East and Africa
10.5.1. By Source
10.5.2. By Product Type
10.5.3. By Service
10.5.4. By Scale of Operation
10.5.5. By Therapeutic Area
10.5.6. By Country
10.5.6.1. Saudi Arabia
10.5.6.1.1. Market Opportunities and Trends
10.5.6.1.2. Growth Prospects
10.5.6.2. UAE
10.5.6.2.1. Market Opportunities and Trends
10.5.6.2.2. Growth Prospects
10.5.6.3. Others
10.5.6.3.1. Market Opportunities and Trends
10.5.6.3.2. Growth Prospects
10.6.Asia Pacific
10.6.1. By Source
10.6.2. By Product Type
10.6.3. By Service
10.6.4. By Scale of Operation
10.6.5. By Therapeutic Area
10.6.6. By Country
10.6.6.1. Japan
10.6.6.1.1. Market Opportunities and Trends
10.6.6.1.2. Growth Prospects
10.6.6.2. China
10.6.6.2.1. Market Opportunities and Trends
10.6.6.2.2. Growth Prospects
10.6.6.3. India
10.6.6.3.1. Market Opportunities and Trends
10.6.6.3.2. Growth Prospects
10.6.6.4. South Korea
10.6.6.4.1. Market Opportunities and Trends
10.6.6.4.2. Growth Prospects
10.6.6.5. Taiwan
10.6.6.5.1. Market Opportunities and Trends
10.6.6.5.2. Growth Prospects
10.6.6.6. Thailand
10.6.6.6.1. Market Opportunities and Trends
10.6.6.6.2. Growth Prospects
10.6.6.7. Indonesia
10.6.6.7.1. Market Opportunities and Trends
10.6.6.7.2. Growth Prospects
10.6.6.8. Others
10.6.6.8.1. Market Opportunities and Trends
10.6.6.8.2. Growth Prospects
11. COMPETITIVE ENVIRONMENT AND ANALYSIS
11.1.Major Players and Strategy Analysis
11.2.Market Share Analysis
11.3.Mergers, Acquisitions, Agreements, and Collaborations
11.4.Competitive Dashboard
12. COMPANY PROFILES
12.1.Boehringer Ingelheim GmbH
12.2.Lonza
12.3.Inno Biologics Sdn Bhd
12.4.JRS PHARMA
12.5.Toyobo Co. Ltd.
12.6.Samsung BioLogics
12.7.WuXi Biologics
12.8.AbbVie, Inc.
12.9.Novartis AG
12.10.ADMA Biologics, Inc.